title: A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
abstract: Poor prognosis of cholangiocarcinoma (CCA) is primarily due to delayed diagnosis because of the lack of appropriate tumor marker(s) to detect cancer development at an early stage. We have recently established a S121 monoclonal antibody (mAb) which recognizes an unidentified glycan epitope on MUC5AC, designated as CCA-associated carbohydrate antigen (CCA-CA). This antigen is expressed in human CCA cells but not in normal biliary epithelia. Detection of CCA-CA effectively distinguished CCA patients' sera from normal control sera with high specificity and sensitivity. In the present study, we examined a time profile of the expression of CCA-CA by immunohistochemical methods in the liver tissues of Opisthorchis viverrini (Ov)-associated CCA in a hamster model. Hamsters were divided into four groups; non-treated, Ov infected, NDMA (N-nitrosodimethamine) treated and Ov+NDMA treated groups, and animals from each group were euthanized at 1, 3 and 6 months post-treatment. CCA-CA was not detected in normal biliary cells of non-treated hamsters throughout the course of experiment. CCA-CA became detectable in the cytoplasm and apical surface of biliary cells of the NDMA and Ov+NDMA groups at early stage (1 month) of tumor development and increased with tumor progression. In contrast, CCA-CA was detected as nuclear staining at the 1 month post Ov infection and declined thereafter. These results suggest the possibility of CCA-CA as an early marker for CCA.
authors.affiliation: Department of Biochemistry, Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. kanlayanee@kkumail.com
authors.forename: Kanlayanee
authors.initials: K
authors.lastname: Sawanyawisuth
authors.forename: Atit
authors.initials: A
authors.lastname: Silsirivanit
authors.forename: Kunlathida
authors.initials: K
authors.lastname: Kunlabut
authors.forename: Nattawat
authors.initials: N
authors.lastname: Tantapotinan
authors.forename: Kulthida
authors.initials: K
authors.lastname: Vaeteewoottacharn
authors.forename: Sopit
authors.initials: S
authors.lastname: Wongkham
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000947:Antigens, Helminth / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D001650:Bile Duct Neoplasms / Q000097:blood* / Q000469:parasitology / Q000473:pathology; D001653:Bile Ducts, Intrahepatic / Q000473:pathology; D014408:Biomarkers, Tumor / Q000097:blood*; D018281:Cholangiocarcinoma / Q000097:blood* / Q000469:parasitology / Q000473:pathology; D006224:Cricetinae; D004195:Disease Models, Animal; D006801:Humans; D007150:Immunohistochemistry / Q000662:veterinary; D008297:Male; D008647:Mesocricetus; D051379:Mice; D008822:Mice, Transgenic; D055271:Mucin 5AC / Q000097:blood* / Q000276:immunology; D009889:Opisthorchiasis / Q000097:blood / Q000150:complications* / Q000469:parasitology / Q000473:pathology; D009891:Opisthorchis / Q000254:growth & development / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000947:Antigens, Helminth; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D055271:Mucin 5AC